Curcumin Alleviates Matrix Metalloproteinase-3 and -9 Activities during Eradication of Helicobacter pylori Infection in Cultured Cells and Mice
暂无分享,去创建一个
I. Pal | A. Mukhopadhyay | D. Saha | S. Swarnakar | Parag Kundu | Ronita De
[1] R. Reiter,et al. Melatonin promotes angiogenesis during protection and healing of indomethacin‐induced gastric ulcer: role of matrix metaloproteinase‐2 , 2010, Journal of pineal research.
[2] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[3] A. Mobasheri,et al. Targeting matrix metalloproteinases in inflammatory conditions. , 2009, Current drug targets.
[4] G. Nair,et al. Antimicrobial Activity of Curcumin against Helicobacter pylori Isolates from India and during Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.
[5] D. Karunagaran,et al. Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. , 2007, International immunopharmacology.
[6] Michael P Vitek,et al. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways , 2007, Proceedings of the National Academy of Sciences.
[7] B. Aggarwal,et al. Role of curcumin in cancer therapy. , 2007, Current problems in cancer.
[8] A. Mobasheri,et al. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. , 2007, Biochemical pharmacology.
[9] Takeshi Azuma,et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium , 2007, Nature Medicine.
[10] D. Berg,et al. Cag Pathogenicity Island-independent Up-regulation of Matrix Metalloproteinases-9 and -2 Secretion and Expression in Mice by Helicobacter pylori Infection* , 2006, Journal of Biological Chemistry.
[11] Kunqian Yu,et al. Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori , 2006, The FEBS journal.
[12] R. Reiter,et al. Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. , 2006, Free radical biology & medicine.
[13] Chang-sheng Deng,et al. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. , 2006, International immunopharmacology.
[14] Christopher M. Overall,et al. Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.
[15] Hee-Sun Kim,et al. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. , 2005, Biochemical and biophysical research communications.
[16] S. Fulda,et al. Betulinic acid as new activator of NF-κB: molecular mechanisms and implications for cancer therapy , 2005, Oncogene.
[17] Jaw-Town Lin,et al. Helicobacter pylori promote gastric cancer cells invasion through a NF-kB and COX-2-mediated pathway , 2005 .
[18] M. Blaser,et al. Matrix Metalloproteinase Secretion by Gastric Epithelial Cells Is Regulated by E Prostaglandins and MAPKs* , 2005, Journal of Biological Chemistry.
[19] P. Maity,et al. Curcumin Regulates Expression and Activity of Matrix Metalloproteinases 9 and 2 during Prevention and Healing of Indomethacin-induced Gastric Ulcer* , 2005, Journal of Biological Chemistry.
[20] P. Kim,et al. Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-γ , 2004, Experimental & Molecular Medicine.
[21] John Bertin,et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.
[22] K. Hahm,et al. Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase , 2004, Gut.
[23] Pascal Richette,et al. Peroxisome Proliferator-activated Receptor-γ Down-regulates Chondrocyte Matrix Metalloproteinase-1 via a Novel Composite Element* , 2004, Journal of Biological Chemistry.
[24] S. Williams,et al. Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. , 2004, Journal of medical microbiology.
[25] P. Bergin,et al. Increased Production of Matrix Metalloproteinases in Helicobacter pylori‐Associated Human Gastritis , 2004, Helicobacter.
[26] M. Naumann,et al. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. , 2004, Biochemical and biophysical research communications.
[27] H. Goto. Helicobacter pylori and gastric diseases. , 2003, Nagoya journal of medical science.
[28] A. Smolka,et al. Interleukin 1β induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection , 2003 .
[29] C. Dinney,et al. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] E. Hahn,et al. H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. , 2003, Medical science monitor : international medical journal of experimental and clinical research.
[31] F. Campbell,et al. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration , 2003, Journal of Cell Science.
[32] S. Falkow,et al. Disruption of the Epithelial Apical-Junctional Complex by Helicobacter pylori CagA , 2003, Science.
[33] T. Hirayama,et al. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. , 2003, Gastroenterology.
[34] G. Mahady,et al. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. , 2002, Anticancer research.
[35] E. Masini,et al. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck , 2002, Cancer.
[36] D. Berg,et al. Virulence Genes in Helicobacter pylori Strains from West Bengal Residents with Overt H. pylori-Associated Disease and Healthy Volunteers , 2002, Journal of Clinical Microbiology.
[37] Y. Surh,et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. , 2001, Mutation research.
[38] J. Pelletier,et al. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. , 2001, Arthritis and rheumatism.
[39] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[40] C. Overall,et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.
[41] H. Pahl,et al. Helicobacter pylori Activates Mitogen-activated Protein Kinase Cascades and Induces Expression of the Proto-oncogenes c-fos and c-jun * , 2000, The Journal of Biological Chemistry.
[42] A. Terano,et al. Chemokine expression in Helicobacter pylori-infected gastric mucosa , 1998, Journal of Gastroenterology.
[43] C. O'Morain,et al. Treatment of Helicobacter pylori , 2005, Helicobacter.
[44] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[45] H. Pahl,et al. A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. , 1997, Journal of immunology.
[46] M. Upton,et al. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. , 1997, Gastroenterology.
[47] Mark Borodovsky,et al. The complete genome sequence of the gastric pathogen Helicobacter pylori , 1997, Nature.
[48] H. Vainio,et al. Working group report on schistosomes, liver flukes and Helicobacter pylori. Meeting held at IARC, LYON, 7–14 june 1994 , 1995, International journal of cancer.
[49] C. Kositchaiwat,et al. Curcuma longa Linn. in the treatment of gastric ulcer comparison to liquid antacid: a controlled clinical trial. , 1993, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[50] A. Shah,et al. Toxicity studies on Alpinia galanga and Curcuma longa. , 1992, Planta medica.
[51] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[52] C. H. Thienes. FUNDAMENTALS OF PHARMACOLOGY , 1945 .
[53] Thomas K. Hunt,et al. ON THE TREATMENT OF , 1846 .
[54] R. Kizek,et al. Matrix metalloproteinases. , 2010, Current medicinal chemistry.
[55] C. Overall,et al. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. , 2010, Biochimica et biophysica acta.
[56] Christopher M Overall,et al. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.
[57] A. Smolka,et al. Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection. , 2003, Gut.